These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 29307569)

  • 21. Intrinsic protein disorder in oncogenic KRAS signaling.
    Nussinov R; Jang H; Tsai CJ; Liao TJ; Li S; Fushman D; Zhang J
    Cell Mol Life Sci; 2017 Sep; 74(17):3245-3261. PubMed ID: 28597297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stabilization of C-RAF:KSR1 complex by DiRas3 reduces availability of C-RAF for dimerization with B-RAF.
    Baljuls A; Dobrzyński M; Rauch J; Rauch N; Kolch W
    Cell Signal; 2016 Oct; 28(10):1451-62. PubMed ID: 27368419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-Arachidonoyl Dopamine Inhibits NRAS Neoplastic Transformation by Suppressing Its Plasma Membrane Translocation.
    Wu M; Huang J; Zhang J; Benes C; Jiao B; Ren R
    Mol Cancer Ther; 2017 Jan; 16(1):57-67. PubMed ID: 27760835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A requirement for wild-type Ras isoforms in mutant KRas-driven signalling and transformation.
    Bentley C; Jurinka SS; Kljavin NM; Vartanian S; Ramani SR; Gonzalez LC; Yu K; Modrusan Z; Du P; Bourgon R; Neve RM; Stokoe D
    Biochem J; 2013 Jun; 452(2):313-20. PubMed ID: 23496764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interrogating the protein interactomes of RAS isoforms identifies PIP5K1A as a KRAS-specific vulnerability.
    Adhikari H; Counter CM
    Nat Commun; 2018 Sep; 9(1):3646. PubMed ID: 30194290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct inhibition of oncogenic KRAS by Bacillus pumilus ribonuclease (binase).
    Ilinskaya ON; Singh I; Dudkina E; Ulyanova V; Kayumov A; Barreto G
    Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1559-67. PubMed ID: 27066977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiplexed screens identify RAS paralogues HRAS and NRAS as suppressors of KRAS-driven lung cancer growth.
    Tang R; Shuldiner EG; Kelly M; Murray CW; Hebert JD; Andrejka L; Tsai MK; Hughes NW; Parker MI; Cai H; Li YC; Wahl GM; Dunbrack RL; Jackson PK; Petrov DA; Winslow MM
    Nat Cell Biol; 2023 Jan; 25(1):159-169. PubMed ID: 36635501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. KRAS
    Zhou ZW; Ambrogio C; Bera AK; Li Q; Li XX; Li L; Son J; Gondi S; Li J; Campbell E; Jin H; Okoro JJ; Xu CX; Janne PA; Westover KD
    Cancer Res; 2020 Sep; 80(17):3719-3731. PubMed ID: 32605999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Principles of K-Ras effector organization and the role of oncogenic K-Ras in cancer initiation through G1 cell cycle deregulation.
    Nussinov R; Tsai CJ; Muratcioglu S; Jang H; Gursoy A; Keskin O
    Expert Rev Proteomics; 2015; 12(6):669-82. PubMed ID: 26496174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The quaternary assembly of KRas4B with Raf-1 at the membrane.
    Jang H; Zhang M; Nussinov R
    Comput Struct Biotechnol J; 2020; 18():737-748. PubMed ID: 32257057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 3-BrPA eliminates human bladder cancer cells with highly oncogenic signatures via engagement of specific death programs and perturbation of multiple signaling and metabolic determinants.
    Konstantakou EG; Voutsinas GE; Velentzas AD; Basogianni AS; Paronis E; Balafas E; Kostomitsopoulos N; Syrigos KN; Anastasiadou E; Stravopodis DJ
    Mol Cancer; 2015 Jul; 14():135. PubMed ID: 26198749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effector Binding Sequentially Alters KRAS Dimerization on the Membrane: New Insights Into RAS-Mediated RAF Activation.
    Lee SY; Eun HJ; Lee KY
    Adv Sci (Weinh); 2024 Oct; 11(38):e2401530. PubMed ID: 39138901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cystine/glutamate antiporter xCT (SLC7A11) facilitates oncogenic RAS transformation by preserving intracellular redox balance.
    Lim JKM; Delaidelli A; Minaker SW; Zhang HF; Colovic M; Yang H; Negri GL; von Karstedt S; Lockwood WW; Schaffer P; Leprivier G; Sorensen PH
    Proc Natl Acad Sci U S A; 2019 May; 116(19):9433-9442. PubMed ID: 31000598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluating The Role Of Nitric Oxide Synthase In Oncogenic Ras-Driven Tumorigenesis.
    Counter C
    Redox Biol; 2015 Aug; 5():417. PubMed ID: 28162280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. KRAS Dimerization Impacts MEK Inhibitor Sensitivity and Oncogenic Activity of Mutant KRAS.
    Ambrogio C; Köhler J; Zhou ZW; Wang H; Paranal R; Li J; Capelletti M; Caffarra C; Li S; Lv Q; Gondi S; Hunter JC; Lu J; Chiarle R; Santamaría D; Westover KD; Jänne PA
    Cell; 2018 Feb; 172(4):857-868.e15. PubMed ID: 29336889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oncogenic and RASopathy-associated K-RAS mutations relieve membrane-dependent occlusion of the effector-binding site.
    Mazhab-Jafari MT; Marshall CB; Smith MJ; Gasmi-Seabrook GM; Stathopulos PB; Inagaki F; Kay LE; Neel BG; Ikura M
    Proc Natl Acad Sci U S A; 2015 May; 112(21):6625-30. PubMed ID: 25941399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Raf inhibitors target ras spatiotemporal dynamics.
    Cho KJ; Kasai RS; Park JH; Chigurupati S; Heidorn SJ; van der Hoeven D; Plowman SJ; Kusumi A; Marais R; Hancock JF
    Curr Biol; 2012 Jun; 22(11):945-55. PubMed ID: 22560614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nras Q61R/+ and Kras-/- cooperate to downregulate Rasgrp1 and promote lympho-myeloid leukemia in early T-cell precursors.
    Wen Z; Yun G; Hebert A; Kong G; Ranheim EA; Finn R; Rajagoplan A; Li S; Zhou Y; Yu M; Damnernsawad A; Roose JP; Coon JJ; Wen R; Wang D; Zhang J
    Blood; 2021 Jun; 137(23):3259-3271. PubMed ID: 33512434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Crosstalk of Ras and Rho: activation of RhoA abates Kras-induced liver tumorigenesis in transgenic zebrafish models.
    Chew TW; Liu XJ; Liu L; Spitsbergen JM; Gong Z; Low BC
    Oncogene; 2014 May; 33(21):2717-27. PubMed ID: 23812423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. KRas4B-PDE6δ complex stabilization by small molecules obtained by virtual screening affects Ras signaling in pancreatic cancer.
    Casique-Aguirre D; Briseño-Díaz P; García-Gutiérrez P; la Rosa CHG; Quintero-Barceinas RS; Rojo-Domínguez A; Vergara I; Medina LA; Correa-Basurto J; Bello M; Hernández-Rivas R; Del RocioThompson-Bonilla M; Vargas M
    BMC Cancer; 2018 Dec; 18(1):1299. PubMed ID: 30594165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.